CD8A and neoplasm: An increased population of CD8α+ DCs in the spleens of ATB-treated mice with ACT results in enhanced ability to cross-present tumor antigens to CD8+ T cells and increased secretion of Th1 cytokines such as IL-12 and IFN-ɤ (80).